{"product_id":"smad1-smad5-smad9-antibody-sc-f2875","title":"Phospho-Smad1\/5\/9 (S463\/465\/467) Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003ePhospho-Smad1\/5\/9 (S463\/465\/467) is a target of interest in many antibody-based workflows. Small Body Size (SMA) and Mothers Against Decapentaplegic family 1 (SMAD1), also known as JV4-1, MADH1, or MADR1, is a gene located on human chromosome 5q4. Initially identified during studies on genes associated with breast cancer, SMAD1 has since been recognized as a crucial regulator in tumor progression. Depending on the literature source, Phospho-Smad1\/5\/9 (S463\/465\/467) may also be discussed as Phospho-Smad1\/5\/9 (S463\/465\/467) and Phospho-Smad1 (Ser463\/465)\/ Smad5 (Ser463\/465)\/ Smad9 (Ser465\/467).\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm, mitochondrion, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following Phospho-Smad1\/5\/9 (S463\/465\/467) across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003ePhospho-Smad1\/5\/9 (S463\/465\/467) is commonly interpreted in the context of cancer, developmental biology, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, mitochondrion, and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm, mitochondrion, and nucleus across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003estage-dependent patterns during differentiation, morphogenesis, or lineage commitment\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Phospho-Smad1\/5\/9 (S463\/465\/467). This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Phospho-Smad1\/5\/9 (S463\/465\/467) reflect biology rather than handling. When interpreting Phospho-Smad1\/5\/9 (S463\/465\/467), it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep Phospho-Smad1\/5\/9 (S463\/465\/467) trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577977676121,"sku":"F2875-20UL","price":199.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577977708889,"sku":"F2875-100UL","price":489.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577977741657,"sku":"F2875-2X100UL","price":729.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2875-wb.gif?v=1773600772","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/smad1-smad5-smad9-antibody-sc-f2875","provider":"Absource Diagnostics","version":"1.0","type":"link"}